– Incyte names new general manager for Biosciences Canada

MONTREAL–(BUSINESS WIRE)–$INCY—Incyte (Nasdaq:INCY) has appointed Christine Lennon as the General Manager for Incyte Biosciences Canada, expanding the its  North American position.

In her role, Christine will be responsible for the development of Incyte’s medical, regulatory and commercial strategy in Canada, Incyte said.

Barry Flannelly, Executive Vice President and Incyte’s General Manager, North America, said that Lennon’s experience and leadership will enable the company to build Incyte Biosciences Canada and establish key development and commercialization capabilities in preparation for potential launches of multiple products in the near future.

“I am thrilled to join Incyte—a company recognized for discovering and developing innovative medicines and bringing them to patients around the world,” said Christine Lennon. “I look forward to leading Incyte Biosciences Canada and bringing Incyte’s medicines to the patients that need them.”